Skip to main navigation
Skip to search
Skip to main content
Help & FAQ
Press / Media
All Ireland Cancer Consortium (AICC2015)
Van Schaeybroeck, S.
School of Medicine, Dentistry and Biomedical Sciences
Centre for Cancer Research and Cell Biology
Participating in or organising an event types
Participation in workshop, seminar, course
Title of talk: MErCuRIC1: A Phase I study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor crizotinib in RASMT and RASWT (with aberrant c-MET) mCRC Patients.
12 May 2015
Belfast, United Kingdom